NCT03240627View on ClinicalTrials.gov

Efficacy and Safety of LH-8 in Paediatric Alopecia Areata

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

March 14, 2022

Study Completion Date

September 14, 2022

Conditions
Alopecia AreataPediatric Disorder
Interventions
DRUG

LH-8

LH-8 cutaneous solution

DRUG

Placebo

Placebo cutaneous solution

Trial Locations (3)

10117

Clinical Research Center for Hair and Skin Science, Charité-Universitätsmedizin Berlin, Berlin

75010

Centre Sabourand - Hospital Saint-Louis, 1, Avenue Claude Vellefaux, Paris

Unknown

Multicenter Clinical Trials, Sofia

Sponsors
All Listed Sponsors
lead

Legacy Healthcare SA

INDUSTRY